Medicine and Dentistry
Patient
100%
Direct Oral Anticoagulant
49%
Therapeutic Procedure
39%
Woman
37%
Venous Thromboembolism
37%
Anticoagulant
35%
Anticoagulation
34%
Vitamin K Antagonist
30%
Rivaroxaban
26%
Thromboprophylaxis
24%
Dentoalveolar Surgery
24%
Anticoagulant Therapy
24%
Antithrombotic
23%
Experience
22%
Clinical Trial
16%
Primary Health Care
13%
Pregnancy
12%
Puerperium
12%
Apixaban
12%
Disease
12%
Child
12%
Acetylsalicylic Acid
12%
D-Dimer
12%
Antibiotic Therapy
12%
Program Effectiveness
12%
Pooled Analysis
12%
Vitamin D
12%
Myeloma
12%
Base
12%
Randomized Controlled Trial
12%
Thrombin
12%
Cohort Analysis
12%
Multiple Myeloma
12%
Alopecia Mucinosa
12%
Prospective Cohort Study
12%
Exploratory Behavior
12%
Hair Loss
12%
Outpatient
12%
Patient Experience
12%
Individualization
12%
Retrospective Cohort Study
12%
Supplementation
10%
Therapeutics
10%
Analysis
9%
Low Molecular Weight Heparin
8%
Heparin
8%
Warfarin
8%
Bleeding
7%
Laboratory Test
7%
Age
7%
Nursing and Health Professions
Anticoagulant Agent
65%
Patient
46%
Woman
37%
Control
28%
Quality of Life
28%
International Normalized Ratio
14%
Prospective Cohort Study
13%
Systematic Review
12%
Consultation
12%
Primary Medical Care
12%
Physician
10%
Clinical Practice
9%
Dose
8%
Adult
8%
Antivitamin K
7%
Compression Stocking
5%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
63%
Enoxaparin
37%
Pharmacology
24%
Anticoagulation Therapy
15%
Clinical Trial
13%
Cohort Study
12%
Elimination
12%
Therapeutic Effect
6%
Pharmacokinetic Modeling
6%
Replacement Therapy
5%
